VONJO is a complement inhibitor indicated for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH)
Generic Name: pacritinib Brand Name: VONJO

What pacritinib is and used for?

Pacritinib, sold under the brand name Vonjo, is an anti-cancer medication used to treat myelofibrosis. It is a macrocyclic protein kinase inhibitor. It mainly inhibits Janus kinase 2 (JAK2) and Fms-like tyrosine kinase 3\CD135 (FLT3).

How can 1 go about obtaining VONJO Capsules?

If VONJO (pacritinib  are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).

Note:
We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

NEWS / UPDATES

• For VONJO (pacritinib)Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details 
• Bristol Myers Squibb Receives European Commission Approval for Onureg® (pacritinib tablets) as Frontline Oral Maintenance Therapy for Adults with Acute Myeloid Leukemia For More Details 
• Bristol Myers Squibb Presents Analyses from Pivotal QUAZAR® AML-001 Study of Onureg® (pacritinib tablets; CC-486) in Adults with Acute Myeloid Leukemia in First Remission For More Details